Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Professional Survey Report 2017

Publisher Name :
Date: 21-Dec-2017
No. of pages: 105
Inquire Before Buying

This report studies Glucagon Like Peptide-1 (GLP-1) Agonists in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

- Novo Nordisk

- AstraZeneca

- Eli Lily

- GSK

- Sanofi

- Bristol-Myers Squibb

- Amylin

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- Exenatied

- Liraglutide

- Lixisenatide

- Abliglutide

- Dulaglutide

By Application, the market can be split into

- Hospital

- Pharmacy

By Regions, this report covers (we can add the regions/countries as you want)

- North America

- China

- Europe

- Southeast Asia

- Japan

- India

If you have any special requirements, please let us know and we will offer you the report as you want.

Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Professional Survey Report 2017

Table of Contents
Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Professional Survey Report 2017
1 Industry Overview of Glucagon Like Peptide-1 (GLP-1) Agonists
1.1 Definition and Specifications of Glucagon Like Peptide-1 (GLP-1) Agonists
1.1.1 Definition of Glucagon Like Peptide-1 (GLP-1) Agonists
1.1.2 Specifications of Glucagon Like Peptide-1 (GLP-1) Agonists
1.2 Classification of Glucagon Like Peptide-1 (GLP-1) Agonists
1.2.1 Exenatied
1.2.2 Liraglutide
1.2.3 Lixisenatide
1.2.4 Abliglutide
1.2.5 Dulaglutide
1.3 Applications of Glucagon Like Peptide-1 (GLP-1) Agonists
1.3.1 Hospital
1.3.2 Pharmacy
1.3.3 Application 3
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
2 Manufacturing Cost Structure Analysis of Glucagon Like Peptide-1 (GLP-1) Agonists
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Glucagon Like Peptide-1 (GLP-1) Agonists
2.3 Manufacturing Process Analysis of Glucagon Like Peptide-1 (GLP-1) Agonists
2.4 Industry Chain Structure of Glucagon Like Peptide-1 (GLP-1) Agonists
3 Technical Data and Manufacturing Plants Analysis of Glucagon Like Peptide-1 (GLP-1) Agonists
3.1 Capacity and Commercial Production Date of Global Glucagon Like Peptide-1 (GLP-1) Agonists Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Glucagon Like Peptide-1 (GLP-1) Agonists Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Glucagon Like Peptide-1 (GLP-1) Agonists Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Glucagon Like Peptide-1 (GLP-1) Agonists Major Manufacturers in 2016
4 Global Glucagon Like Peptide-1 (GLP-1) Agonists Overall Market Overview
4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2012-2017E Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity and Growth Rate Analysis
4.2.2 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2012-2017E Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Growth Rate Analysis
4.3.2 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2012-2017E Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price
4.4.2 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price Analysis (Company Segment)
5 Glucagon Like Peptide-1 (GLP-1) Agonists Regional Market Analysis
5.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Analysis
5.1.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Overview
5.1.2 North America 2012-2017E Glucagon Like Peptide-1 (GLP-1) Agonists Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2012-2017E Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price Analysis
5.1.4 North America 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Market Share Analysis
5.2 China Glucagon Like Peptide-1 (GLP-1) Agonists Market Analysis
5.2.1 China Glucagon Like Peptide-1 (GLP-1) Agonists Market Overview
5.2.2 China 2012-2017E Glucagon Like Peptide-1 (GLP-1) Agonists Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2012-2017E Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price Analysis
5.2.4 China 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Market Share Analysis
5.3 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Analysis
5.3.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Overview
5.3.2 Europe 2012-2017E Glucagon Like Peptide-1 (GLP-1) Agonists Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2012-2017E Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price Analysis
5.3.4 Europe 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Market Share Analysis
5.4 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Market Analysis
5.4.1 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Market Overview
5.4.2 Southeast Asia 2012-2017E Glucagon Like Peptide-1 (GLP-1) Agonists Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2012-2017E Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price Analysis
5.4.4 Southeast Asia 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Market Share Analysis
5.5 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Market Analysis
5.5.1 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Market Overview
5.5.2 Japan 2012-2017E Glucagon Like Peptide-1 (GLP-1) Agonists Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2012-2017E Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price Analysis
5.5.4 Japan 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Market Share Analysis
5.6 India Glucagon Like Peptide-1 (GLP-1) Agonists Market Analysis
5.6.1 India Glucagon Like Peptide-1 (GLP-1) Agonists Market Overview
5.6.2 India 2012-2017E Glucagon Like Peptide-1 (GLP-1) Agonists Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2012-2017E Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price Analysis
5.6.4 India 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Market Share Analysis
6 Global 2012-2017E Glucagon Like Peptide-1 (GLP-1) Agonists Segment Market Analysis (by Type)
6.1 Global 2012-2017E Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type
6.2 Different Types of Glucagon Like Peptide-1 (GLP-1) Agonists Product Interview Price Analysis
6.3 Different Types of Glucagon Like Peptide-1 (GLP-1) Agonists Product Driving Factors Analysis
6.3.1 Exenatied of Glucagon Like Peptide-1 (GLP-1) Agonists Growth Driving Factor Analysis
6.3.2 Liraglutide of Glucagon Like Peptide-1 (GLP-1) Agonists Growth Driving Factor Analysis
6.3.3 Lixisenatide of Glucagon Like Peptide-1 (GLP-1) Agonists Growth Driving Factor Analysis
6.3.4 Abliglutide of Glucagon Like Peptide-1 (GLP-1) Agonists Growth Driving Factor Analysis
6.3.5 Dulaglutide of Glucagon Like Peptide-1 (GLP-1) Agonists Growth Driving Factor Analysis
7 Global 2012-2017E Glucagon Like Peptide-1 (GLP-1) Agonists Segment Market Analysis (by Application)
7.1 Global 2012-2017E Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Application
7.2 Different Application of Glucagon Like Peptide-1 (GLP-1) Agonists Product Interview Price Analysis
7.3 Different Application of Glucagon Like Peptide-1 (GLP-1) Agonists Product Driving Factors Analysis
7.3.1 Hospital of Glucagon Like Peptide-1 (GLP-1) Agonists Growth Driving Factor Analysis
7.3.2 Pharmacy of Glucagon Like Peptide-1 (GLP-1) Agonists Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Glucagon Like Peptide-1 (GLP-1) Agonists
8.1 Novo Nordisk
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Novo Nordisk 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Novo Nordisk 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Business Region Distribution Analysis
8.2 AstraZeneca
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 AstraZeneca 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 AstraZeneca 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Business Region Distribution Analysis
8.3 Eli Lily
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Eli Lily 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Eli Lily 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Business Region Distribution Analysis
8.4 GSK
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 GSK 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 GSK 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Business Region Distribution Analysis
8.5 Sanofi
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Sanofi 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Sanofi 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Business Region Distribution Analysis
8.6 Bristol-Myers Squibb
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Bristol-Myers Squibb 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Bristol-Myers Squibb 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Business Region Distribution Analysis
8.7 Amylin
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Amylin 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Amylin 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Business Region Distribution Analysis
9 Development Trend of Analysis of Glucagon Like Peptide-1 (GLP-1) Agonists Market
9.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Trend Analysis
9.1.1 Global 2017-2022 Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (Volume and Value) Forecast
9.1.2 Global 2017-2022 Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price Forecast
9.2 Glucagon Like Peptide-1 (GLP-1) Agonists Regional Market Trend
9.2.1 North America 2017-2022 Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Forecast
9.2.2 China 2017-2022 Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Forecast
9.2.3 Europe 2017-2022 Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Forecast
9.2.4 Southeast Asia 2017-2022 Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Forecast
9.2.5 Japan 2017-2022 Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Forecast
9.2.6 India 2017-2022 Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Forecast
9.3 Glucagon Like Peptide-1 (GLP-1) Agonists Market Trend (Product Type)
9.4 Glucagon Like Peptide-1 (GLP-1) Agonists Market Trend (Application)
10 Glucagon Like Peptide-1 (GLP-1) Agonists Marketing Type Analysis
10.1 Glucagon Like Peptide-1 (GLP-1) Agonists Regional Marketing Type Analysis
10.2 Glucagon Like Peptide-1 (GLP-1) Agonists International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Glucagon Like Peptide-1 (GLP-1) Agonists by Region
10.4 Glucagon Like Peptide-1 (GLP-1) Agonists Supply Chain Analysis
11 Consumers Analysis of Glucagon Like Peptide-1 (GLP-1) Agonists
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
12 Conclusion of the Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Professional Survey Report 2017
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Picture of Glucagon Like Peptide-1 (GLP-1) Agonists
Table Product Specifications of Glucagon Like Peptide-1 (GLP-1) Agonists
Table Classification of Glucagon Like Peptide-1 (GLP-1) Agonists
Figure Global Production Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Type in 2016
Figure Exenatied Picture
Table Major Manufacturers of Exenatied
Figure Liraglutide Picture
Table Major Manufacturers of Liraglutide
Figure Lixisenatide Picture
Table Major Manufacturers of Lixisenatide
Figure Abliglutide Picture
Table Major Manufacturers of Abliglutide
Figure Dulaglutide Picture
Table Major Manufacturers of Dulaglutide
Table Applications of Glucagon Like Peptide-1 (GLP-1) Agonists
Figure Global Consumption Volume Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Application in 2016
Figure Hospital Examples
Table Major Consumers in Hospital
Figure Pharmacy Examples
Table Major Consumers in Pharmacy
Figure Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Regions
Figure North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (Million USD) (2012-2022)
Figure China Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (Million USD) (2012-2022)
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (Million USD) (2012-2022)
Figure Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (Million USD) (2012-2022)
Figure Japan Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (Million USD) (2012-2022)
Figure India Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (Million USD) (2012-2022)
Table Glucagon Like Peptide-1 (GLP-1) Agonists Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Glucagon Like Peptide-1 (GLP-1) Agonists in 2016
Figure Manufacturing Process Analysis of Glucagon Like Peptide-1 (GLP-1) Agonists
Figure Industry Chain Structure of Glucagon Like Peptide-1 (GLP-1) Agonists
Table Capacity and Commercial Production Date of Global Glucagon Like Peptide-1 (GLP-1) Agonists Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Glucagon Like Peptide-1 (GLP-1) Agonists Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Glucagon Like Peptide-1 (GLP-1) Agonists Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Glucagon Like Peptide-1 (GLP-1) Agonists Major Manufacturers in 2016
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Glucagon Like Peptide-1 (GLP-1) Agonists 2012-2017
Figure Global 2012-2017E Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (Value) and Growth Rate
Table 2012-2017E Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity and Growth Rate
Table 2016 Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity (K Units) List (Company Segment)
Table 2012-2017E Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) and Growth Rate
Table 2016 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) List (Company Segment)
Table 2012-2017E Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price (USD/Unit)
Table 2016 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Glucagon Like Peptide-1 (GLP-1) Agonists 2012-2017E
Figure North America 2012-2017E Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price (USD/Unit)
Figure North America 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Glucagon Like Peptide-1 (GLP-1) Agonists 2012-2017E
Figure China 2012-2017E Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price (USD/Unit)
Figure China 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Glucagon Like Peptide-1 (GLP-1) Agonists 2012-2017E
Figure Europe 2012-2017E Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price (USD/Unit)
Figure Europe 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Glucagon Like Peptide-1 (GLP-1) Agonists 2012-2017E
Figure Southeast Asia 2012-2017E Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price (USD/Unit)
Figure Southeast Asia 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Glucagon Like Peptide-1 (GLP-1) Agonists 2012-2017E
Figure Japan 2012-2017E Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price (USD/Unit)
Figure Japan 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Glucagon Like Peptide-1 (GLP-1) Agonists 2012-2017E
Figure India 2012-2017E Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price (USD/Unit)
Figure India 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share
Table Global 2012-2017E Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Type
Table Different Types Glucagon Like Peptide-1 (GLP-1) Agonists Product Interview Price
Table Global 2012-2017E Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Application
Table Different Application Glucagon Like Peptide-1 (GLP-1) Agonists Product Interview Price
Table Novo Nordisk Information List
Table Product A Overview
Table Product B Overview
Table 2016 Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Business Region Distribution
Table AstraZeneca Information List
Table Product A Overview
Table Product B Overview
Table 2016 AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Business Region Distribution
Table Eli Lily Information List
Table Product A Overview
Table Product B Overview
Table 2015 Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Business Region Distribution
Table GSK Information List
Table Product A Overview
Table Product B Overview
Table 2016 GSK Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 GSK Glucagon Like Peptide-1 (GLP-1) Agonists Business Region Distribution
Table Sanofi Information List
Table Product A Overview
Table Product B Overview
Table 2016 Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Business Region Distribution
Table Bristol-Myers Squibb Information List
Table Product A Overview
Table Product B Overview
Table 2016 Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Business Region Distribution
Table Amylin Information List
Table Product A Overview
Table Product B Overview
Table 2016 Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Business Region Distribution
Figure Global 2017-2022 Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (K Units) and Growth Rate Forecast
Figure Global 2017-2022 Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price (USD/Unit) Forecast
Figure North America 2017-2022 Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2017-2022 Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2017-2022 Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2017-2022 Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2017-2022 Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of Glucagon Like Peptide-1 (GLP-1) Agonists by Type 2017-2022
Table Global Consumption Volume (K Units) of Glucagon Like Peptide-1 (GLP-1) Agonists by Application 2017-2022
Table Traders or Distributors with Contact Information of Glucagon Like Peptide-1 (GLP-1) Agonists by Region
  • 2018-2023 Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Report
    Published: 19-Jul-2018        Price: US 4660 Onwards        Pages: 136
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Glucagon Like Peptide-1 (GLP-1) Agonists market for 2018-2023. Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia......
  • 2018 Top 5 Glucagon Like Peptide-1 (GLP-1) Agonists Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa
    Published: 19-Jul-2018        Price: US 4960 Onwards        Pages: 123
    Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia. United States is the largest consumer of Glucagon like peptide-1 (GLP-1) agonists with the production market share of 35% and the consumption market share of 44% in 2015. The second place ......
  • Global Insulin Glargine Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 06-Jul-2018        Price: US 3480 Onwards        Pages: 118
    Insulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile (according to the insulin glargine package insert). Scope of the Report: This report focuses on the Insulin Glargine in global market, especially in North Ame......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Insulin Glargine Market 2018, Forecast to 2023
    Published: 06-Jul-2018        Price: US 4880 Onwards        Pages: 112
    Insulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile (according to the insulin glargine package insert). Scope of the Report: This report focuses on the Insulin Glargine in global market, especially in North Ame......
  • Global Glucagon Like Peptide-1 (GLP-1) Agonists Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 05-Jul-2018        Price: US 3480 Onwards        Pages: 130
    Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia. Scope of the Report: This report focuses on the Glucagon Like Peptide-1 (GLP-1) Agonists in global market, especially in North America, Europe and Asia-Pacific, South America, Midd......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Glucagon Like Peptide-1 (GLP-1) Agonists Market 2018, Forecast to 2023
    Published: 05-Jul-2018        Price: US 4880 Onwards        Pages: 130
    Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia. Scope of the Report: This report focuses on the Glucagon Like Peptide-1 (GLP-1) Agonists in global market, especially in North America, Europe and Asia-Pacific, South America, Midd......
  • 2018-2023 Global Glucagon Consumption Market Report
    Published: 26-Jun-2018        Price: US 4660 Onwards        Pages: 134
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Glucagon market for 2018-2023. Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose ......
  • 2018 Top 5 Glucagon Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa
    Published: 26-Jun-2018        Price: US 4960 Onwards        Pages: 121
    Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release s......
  • Global Insulin Glargine Sales Market Report 2018
    Published: 20-Jun-2018        Price: US 4000 Onwards        Pages: 108
    This report studies the global Insulin Glargine market status and forecast, categorizes the global Insulin Glargine market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Insulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to h......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs